Alessandro Arosio
Monza, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: October 31, 2019
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis.
Journal: Progress in neurobiology
Published: June 23, 2019
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes.
Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
Published: May 23, 2018
Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.
Journal: Frontiers in molecular neuroscience
Published: October 27, 2016
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
Journal: Neurotoxicology
Published: November 04, 2015
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Journal: Molecular and cellular neurosciences
Published: June 08, 2015
BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis.
Journal: Neuro-degenerative diseases
Published: March 20, 2015
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease.
Journal: Brain research
Published: October 16, 2013
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition.
Journal: BioMed research international
Published: April 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026